IL-6 gene alteration linked to reduced cardiometabolic risk
A genetic study shows that perturbation of IL-6 signaling, mimicking IL-6 inhibition, is associated with reduced risk of cardiovascular diseases, diabetes, and certain infections, supporting IL-6 as a promising therapeutic target for cardiometabolic conditions, while also highlighting potential safety concerns.